Showing 2 of 2 recruiting trials for “immune-mediated-necrotizing-myopathy”
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
👨⚕️ Julie Paik, M.D., M.H.S., Johns Hopkins Hospital: Division of Rheumatology📍 9 sites📅 Started Feb 2026View details ↗
The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy
👨⚕️ James Andrews, MD, University of Alabama at Birmingham📍 5 sites📅 Started Oct 2025View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →